Frequency of HLA alleles and KIR Ligands in Acute Myeloid Leukemia in Indian Cohort

[1]  V. Varbanova,et al.  Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study , 2019, Turkish journal of haematology : official journal of Turkish Society of Haematology.

[2]  M. Carrington,et al.  Natural Killer Cells Offer Differential Protection From Leukemia in Chinese Southern Han , 2019, Front. Immunol..

[3]  M. Cantorna,et al.  Vitamin D Is Required for ILC3 Derived IL-22 and Protection From Citrobacter rodentium Infection , 2019, Front. Immunol..

[4]  J. Boudreau,et al.  Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned. , 2018, Trends in immunology.

[5]  Meenakshi Singh,et al.  Killer Immunoglobulin like Receptor-Human Leukocyte Antigen Ligand Match/Mismatch in Graft Loss Post Transplant Cyclophosphamide Based Hap loidentical Transplant , 2018 .

[6]  P. Norman,et al.  Deciphering the killer‐cell immunoglobulin‐like receptor system at super‐resolution for natural killer and T‐cell biology , 2016, Immunology.

[7]  S. Prakash,et al.  Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians. , 2016, Human immunology.

[8]  H. H. Akar,et al.  Relationships of Human Leukocyte Antigen-A, -B, -DRB1 Alleles, and Haplotypes in 129 Ethnic Turkish Patients With Acute Myeloblastic Leukemia. , 2015, Laboratory medicine.

[9]  G. Vassiliou,et al.  Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer? , 2014, Disease Models & Mechanisms.

[10]  A. Chokkalingam,et al.  The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia. , 2014, Blood.

[11]  J. Granados,et al.  HLA-B*40 Allele Plays a Role in the Development of Acute Leukemia in Mexican Population: A Case-Control Study , 2013, BioMed research international.

[12]  R. Rajalingam.  Human diversity of killer cell immunoglobulin-like receptors and disease , 2011, The Korean journal of hematology.

[13]  E. Erduran,et al.  Relation of HLA-A, -B, -DRB1 alleles and haplotypes in patients with acute leukemia: a case control study. , 2011, Archives of medical research.

[14]  S. Vojvodić,et al.  HLA class II antigens and haplotypes associated with susceptibility of leukemias and myelodysplastic syndrome , 2011 .

[15]  G. Gedikoğlu,et al.  The Frequency of HLA Class I and II Alleles in Turkish Childhood Acute Leukaemia Patients , 2010, The Journal of international medical research.

[16]  M. Kraemer,et al.  Molecular identification of the HLA-DRB1-DQB1 for diagnosis and follow-up of acute leukemias. , 2010, Blood cells, molecules & diseases.

[17]  E. Thorsby,et al.  A short history of HLA. , 2009, Tissue antigens.

[18]  N. Mehra.  The HLA genes and their diverse polymorphism , 2000, Indian Journal of Clinical Biochemistry.

[19]  K. Alimoghadam,et al.  HLA class II allele and haplotype frequencies in Iranian patients with leukemia. , 2007, Iranian journal of allergy, asthma, and immunology.

[20]  P. Wernet,et al.  Relevance of C1 and C2 Epitopes for Hemopoietic Stem Cell Transplantation: Role for Sequential Acquisition of HLA-C-Specific Inhibitory Killer Ig-Like Receptor1 , 2007, The Journal of Immunology.

[21]  C. Kalberer,et al.  Function of natural killer cells in immune defence against human leukaemia. , 2006, Swiss medical weekly.

[22]  F. Christiansen,et al.  KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[23]  E. Weiss,et al.  Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6 , 2006, Immunogenetics.

[24]  Y. Badrinath,et al.  Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial Hospital. , 2003, Indian journal of cancer.

[25]  G. Morgan,et al.  Allele and haplotype frequency at human leucocyte antigen class I/II and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: in search of an autoimmune aetiology , 2002, British journal of haematology.

[26]  H. Ljunggren,et al.  In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.

[27]  A. Rimm,et al.  HLA associations with leukemia. , 1987, Blood.

[28]  S. Seremetis,et al.  Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope. , 1985, The Journal of clinical investigation.